Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: An institutional experience

被引:4
作者
Singh, Priti [1 ]
Kaushik, Sanjay [1 ]
Thakur, Brijesh [1 ,2 ]
Acharya, Seema [1 ]
Bhardwaj, Aparna [1 ]
Bahal, Neelima [1 ]
机构
[1] Shri Guru Ram Rai Inst Med & Hlth Sci, Dept Pathol, Dehra Dun, Uttarakhand, India
[2] SGRRIM & HS, Dept Pathol, Dehra Dun 248001, Uttarakhand, India
关键词
Cervix; HPV; p16; ki-67; SIL; SCC; HPV-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS INFECTION; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; CANCER; EXPRESSION; P16(INK4A); RISK; EFFICACY; PROTEIN;
D O I
10.4103/ijpm.ijpm_656_21
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: The present study evaluates the immunoexpression of p16 and Ki-67 in cervical squamous intraepithelial lesion (SIL) and carcinomas and correlates their expression with clinicopathological features and HPV-DNA status. Material and Methods: A total 36 included cases of SIL and squamous cell carcinoma (SCC) were subjected to p16 and Ki-67 immunostaining. p16 staining was evaluated depending on grading, distribution, localization pattern, intensity and IHC score. Ki-67 expression was graded based on percentage of positive cells. Results: Incidence of HSIL and SCC cases was found to be significantly increased with parity > 5. p16 grade III diffuse nucleocytoplasmic immunostaining was observed in 62.5% LSIL, 80% HSIL and 87% SCC cases. Significant association of p16 staining intensity, IHC score and Ki-67 indices was noted with increasing grades of SILs and carcinomas. Conclusion: Our experience indicates that a combination of p16 and Ki-67 immunostaining may be useful to determine the severity of dysplastic change.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 28 条
[1]   Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J].
Arbyn, Marc ;
Weiderpass, Elisabete ;
Bruni, Laia ;
de Sanjose, Silvia ;
Saraiya, Mona ;
Ferlay, Jacques ;
Bray, Freddie .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E191-E203
[2]   Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions [J].
Benevolo, M ;
Mottolese, M ;
Marandino, F ;
Vocaturo, G ;
Sindico, R ;
Piperno, G ;
Mariani, L ;
Sperduti, I ;
Canalini, P ;
Donnorso, RP ;
Vocaturo, A .
MODERN PATHOLOGY, 2006, 19 (03) :384-391
[3]   Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening Programs [J].
Brown, Charlotte A. ;
Bogers, Johnannes ;
Sahebali, Shaira ;
Depuydt, Christophe E. ;
De Prins, Frans ;
Malinowski, Douglas P. .
JOURNAL OF ONCOLOGY, 2012, 2012
[4]  
Davis M, 2016, CURR OBSTET GYNECOL, V5, P307, DOI 10.1007/s13669-016-0180-0
[5]   Protein p 16INK4A expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of uterine cervix [J].
Gupta, Ruchi ;
Srinivasan, Radhika ;
Nijhawan, Raje ;
Suri, Vanita ;
Uppal, Radha .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (01) :7-11
[6]  
Hebbar Ankitha, 2017, J Lab Physicians, V9, P104, DOI [10.4103/0974-2727.199630, 10.4103/0974-2727.199630]
[7]  
Jacob AA, 2018, International Journal of Research in Medical Sciences, V6, P882, DOI 10.18203/2320-6012.ijrms20180608
[8]   Clinicopathological Presentation of Cervical Cancer in Bhopal [J].
Jain, Rubal ;
Nigam, Rajendra Kumar ;
Malik, Reeni ;
Jain, Pramila .
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 :S33-S37
[9]  
Kanthiya Kanjana, 2016, Asian Pac J Cancer Prev, V17, P3201
[10]   Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis [J].
Keating, JT ;
Ince, T ;
Crum, CP .
ADVANCES IN ANATOMIC PATHOLOGY, 2001, 8 (02) :83-92